Position in TBPH
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$252,161
+$11,422 QoQ
Shares Held
14,833
0.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#105
of 180 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JAMES INVESTMENT RESEARCH, INC. holds $7,400,403 across 7 Biotechnology names. TBPH ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
26,578 | $2,080,260 | |
| 2 | INVA |
Innoviva, Inc.
|
81,609 | $1,853,340 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
17,122 | $1,488,757 | |
| 4 | 43,686 | $1,373,050 | |||
| 5 | ZYME |
Zymeworks Inc.
|
10,925 | $285,579 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
This page
|
14,833 | $252,161 | |
| 7 | IRD |
Opus Genetics, Inc.
|
16,364 | $67,256 |
All Filings in TBPH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $252,161 | 14,833 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $240,739 | 14,833 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $277,525 | 14,833 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||